Sanofi's Genzyme Announces New Analysis Suggests Aubagio Slows Brain Atrophy in People with Relapsing MS

By: via Benzinga
Genzyme, a Sanofi (NYSE: SNY) company, announced today that magnetic resonance imaging (MRI) data from the Phase III TEMSO study ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.